CANCER THERAPY PROTOCOL:
FAQ
about the AMAS Test
The AMAS®TEST is a simple blood test which measures
serum levels of AMA (Anti-Malignin Antibody) found
to be elevated in most patients with a wide range
of active non-terminal malignancies.
The
AMAS® Cancer Test
An innovative aid in early cancer diagnosis and followup
AMAS
Test
This study is designed to determine the efficacy of
the LifeOne on terminal cancer patients. Efficacy
is to be determined by remission only. CEA, PSÁ,
CA125 and other specific antigen tests will be used
when possible to help verify remission. However, AMAS
testing in the normal range will be the only accepted
final test to determine remission. Other testing to
be completed will be CBC, Comprehensive Metabolic
and Lymphocyte Subset Panel (lymphocyte immunophenotype
enumeration) including Natural Killer Cell Functional
Assay. These tests will determine the effect of LifeOne
on the immune system as well as verify the AMAS results.
Candidates for the research must have undergone biopsy
to verify malignancy. CBC's with all immune markers
in the normal range will be required to determine
validity of the AMAS test.
Prior use of chemotherapy or radiation will not disqualify
participants. However, all patients must have been
without other therapies for at least 3 months prior
to beginning the study, and must show active cancer.
Dosage
for all people using LifeOne should be the same.
1.
1/2 ounce or 15 ml. three times daily.
2. All people using LifeOne should be instructed to
eliminate sugar and simple carbohydrates from their
diet.
3. All people using LifeOne should be instructed to
exercise regularly if able.
4. All people using LifeOne responses will be recorded.
5. All test results will be recorded.
Other
cancer patients who wish to participate in the research
will be treated with the same protocol.
AMAS
Test
Because
the A.M.A.S. is an actual antibody test, it requires
that the body be able to manufacture antibodies for
accurate results. I have found that lymphocyte subset
panels, that show the patient within the reference
range, produce a consistent and accurate AMAS reading.
However, patients with lymphocyte subset panels which
range in the lower third of the subset ranges produce
borderline AMAS test results in many cases. As the
immune system improves, as demostrated by the lymphocyte
subset panel, the AMAS reading becomes a reliable
indicator and shows a positive finding for cancer.
This does not mean the cancer has worsened. It simply
means that immune system has become more able to produce
antibodies to malignan. Within 6-8 weeks after this
increase in the A.M.A.S., the A.M.A.S. test results
should show a steady decline to a normal range. This
will occur as the subset panel shows movement toward
the upper third of the reference range.
The
most valuable tool in evaluating the efficacy of treatment
is clinical observation. Most patients will respond
within a week, showing decreased pain, increased energy,
and a general feeling of increased vigor. It is important
to take careful clinical notes on the patient's general
feelings and how they present themselves.
If patients are currently on pain medication, as the
pain decreases, it is important to decrease the pain
medication. All pain medications have side effects,
and may inhibit absorption of needed phytochemicals.
Opiates have been shown to increase some cancers'
growth and metastasis. If opiates are required for
patient comfort, they may be prescribed . However,
decrease as the pain decreases.
Palpate
breast tumors regularly. Dramatic decreases in tumor
size within a 2-week period are very common. It is
also common to have breast tenderness decrease or
disappear altogether, within a week or two. It is
important to have CT scans for verification of both
presence and regression of breast tumors.
Pictures
of skin lesions including basal cell and squamous
cell carcinomas are important. They will often fall
off in a period of 10-30 days. Digital photos of many
cases will be helpful. They must be taken before any
therapeutic intervention.
Glucose
IV's are contraindicated with cancer patients. I realize
this goes against common practice, but research dictates
that if vitamins or minerals need a medium for dissolution,
a saline solution is preferred.
Do not raise the serum glucose levels artificially.
Digestive enzymes are very helpful in many cases,
especially when digestive problems are present.
AIDS
PROTOCOL:
Make sure the patient that is going to try the formula
has enough for at least 40 days. This is a good time
to retest for new baselines.
Initial Visit Protocol:
The
first visit is used to get a thorough and detailed
case history, counsel the patient on the importance
of diet and nutrition, explain the purpose of the
lab tests to be done and instruct them in the use
of the suggested supplements. Thorough examination
of the skin should also be done at this time. Biopsy¹s
should be taken of suspicious lesions whenever possible.
AIDs and HIV Protocol:
The following tests should be done on the first visit:
CBC
Comprehensive Metabolic Panel
Lymphocyte Immunophenotype Enumeration (lymphocyte
subset panel)
HIV/RNA viral load
After
baseline labs, all lab tests should be repeated every
30 days in order to accurately monitor remission or
progression of the disease, as well as clinical changes
that may go unnoticed.
Normal
clinical notes concerning general health status, compliance
with diet, weight, etc., must also be taken at least
every 2 weeks for the first 30 days, and every 30
days thereafter.
Diet:
When possible
The
diet must eliminate all simple sugars and simple carbohydrates.
The
diet should consist of large amounts of fresh vegetables,
fish, poultry, fruits etc., but breads, white flour,
corn, white potatoes, white rice etc., must be eliminated
to aid in the control of glucose levels.
Protein
intake should be 50-80 grams/day. This should be supplemented
with whey isolate protein drinks when possible. Low
carb/high protein, and easily assimilated.
Drink
large amounts of distilled water. 1 fluid ounce per
2 lbs. of body weight per day. It is extremely important
to keep the body flushed with pure water. 180 lb.
man should drink 90 ounces of water daily.
As
an adjunctive, I use Solaray¹s Spectro without
iron. The normal dosage is 2 capsule TID with meals.
Other supplements may be helpful, but these should
be discussed on a case-by-case basis with the attending
physician.
Side
effects:
The
only side effects noted so far have been loose stool
that usually self corrects within a week or two. Some
patients also object to the taste. Any other side
effects should be noted in the patient charts. Though
we have had no allergic reactions, the possibility
always exists, so careful monitoring is needed.
Notes:
Get the patients back for a follow-up as soon as blood
results are in. Explain the meaning of all blood work
carefully so the patient understands everything about
the progression and remission of their disease. The
next visit would be a follow-up in 2 weeks, then 30
days, etc.
Blood
pressures are showing a strong tendency to drop in
hypertensive patients. This must be monitored carefully.
This is especially important with patients currently
on beta-blockers, calcium channel blockers, etc. In
almost all of my cases, these medications were no
longer needed within 8 weeks.
